natgillin/translations-raw huggingface dataset:
The measure of effectiveness in the studies was based on the assessment by the dog owner of the severity of the pruritus and improvements in the dog's behaviour using a standard scale.
Merilo učinkovitosti v študijah je temeljilo na oceni resnosti pruritusa in izboljšanjih obnašanja psa, ki jo je podal lastnik psa na podlagi standardne lestvice.
What benefit has Apoquel shown during the studies?
Kakšne koristi je zdravilo Apoquel izkazalo med študijami?
The benefit/risk balance may be found in the scientific discussion module of this EPAR.
Razmerje med koristmi in tveganji je na voljo v modulu o znanstveni razpravi tega evropskega javnega poročila o oceni zdravila (EPAR).
The atopic dermatitis indication was also investigated in two field studies.
Indikacijo atopični dermatitis so prav tako preučevali v dveh terenskih študijah.
For the appropriate strength of tablets and number of tablets to be given, see the dosage table in the package leaflet.
Za ustrezne jakosti tablet in število potrebnih tablet glejte tabelo o odmerjanju v navodilu za uporabo.
In both, Apoquel was compared with placebo.
V obeh študijah so zdravilo Apoquel primerjali s placebom.
Studies in atopic dermatitis also used assessment of skin lesions on a score known as the canine atopic dermatitis extent and severity index (CADESI).
V študijah atopičnega dermatitisa so ocenjevali tudi kožne lezije v skladu z lestvico, ki se imenuje indeks obsega in resnosti atopičnega dermatitisa pri psih (canine atopic dermatitis extent and severity index, CADESI).
What is the risk associated with Apoquel?
Kakšna tveganja so povezana z zdravilom Apoquel?
These enzymes play an important role in the processes of inflammation and itchiness including those involved in allergic dermatitis and atopic dermatitis in dogs.
Ti encimi imajo pomembno vlogo v procesih vnetja in srbenja, vključno s tistimi, ki prisotni pri alergijskem in atopičnem dermatitisu pri psih.
In case of accidental ingestion, medical advice should be sought immediately and the package leaflet or the label shown to the doctor.
V primeru nenamernega zaužitja zdravila se je treba takoj posvetovati z zdravnikom in mu pokazati navodilo za uporabo ali nalepko na ovojnini.
It is also used in dogs to treat atopic dermatitis.
Uporablja se tudi za zdravljenje atopičnega dermatitisa pri psih.
In the pruritus study comparing Apoquel with prednisolone, both medicines were shown to be effective, with a successful response seen in 68% of dogs treated with Apoquel, and 76% of those treated with prednisolone.
V študiji pruritusa, v kateri so zdravilo Apoquel primerjali s prednizolonom, sta se obe zdravili izkazali kot učinkoviti, z uspešnim odzivom pri 68 % psov, ki so prejemali zdravilo Apoquel, in 76 % pri psih, ki so prejemali prednizolon.
The action of Apoquel in pruritus associated with allergic dermatitis was studied in two field studies.
Delovanje zdravila Apoquel pri pruritusu, povezanim z alergijskim dermatitisom, so preučevali v dveh terenskih študijah.
In one, Apoquel was compared with prednisolone (an immunosuppressant) in 220 dogs, and in the other Apoquel was compared with placebo (dummy treatment) in 436 dogs.
V eni študiji so zdravilo Apoquel primerjali s prednizolonom (imunosupresivom) pri 220 psih, v drugi pa so zdravilo Apoquel primerjali s placebom (zdravilom brez zdravilne učinkovine) pri 436 psih.
Why has Apoquel been approved?
Zakaj je bilo zdravilo Apoquel odobreno?
By blocking the enzymes, Apoquel reduces the inflammation and itchiness associated with the disease.
Zdravilo Apoquel prepreči delovanje encimov in s tem zmanjša vnetje in srbenje, povezano z boleznijo.
The most common side effects were diarrhoea, vomiting and loss of appetite in decreasing order of frequency.
Najpogostejši neželeni učinki, navedeni po padajoči pogostnosti, so bili driska, bruhanje in pomanjkanje teka.
For a full list of all side-effects reported with Apoquel, see the package leaflet.
Za celoten seznam neželenih učinkov, o katerih so poročali pri uporabi zdravila Apoquel, glejte navodilo za uporabo.
Apoquel is used in dogs to treat pruritus (itching) associated with allergic dermatitis (inflammation of the skin).
Zdravilo Apoquel se uporablja za zdravljenje pruritusa (srbenja), povezanega z alergijskim dermatitisom (vnetjem kože) pri psih.
Apoquel is a veterinary medicine that contains the active substance oclaticinib.
Apoquel je zdravilo za uporabo v veterinarski medicini, ki vsebuje zdravilno učinkovino oklacitinib.
What is Apoquel used for?
Za kaj se zdravilo Apoquel uporablja?
When compared with placebo, the success rate was 67% for Apoquel-treated dogs and 29% for placebo-treated dogs.
Pri primerjavi s placebom je bila stopnja uspešnosti pri psih, ki so prejemali zdravilo Apoquel, 67 %, pri psih, ki so prejemali placebo, pa 29 %.
How has Apoquel been studied?
Kako je bilo zdravilo Apoquel raziskano?
Apoquel should not be given to dogs less than one year of age or weighing less than 3 kg. Apoquel should not be given to dogs with signs of immune suppression or progressive cancer as Apoquel has not been studied in such cases.
Zdravila Apoquel ni dovoljeno dajati psom, ki kažejo znake imunosupresije ali progresivnega raka, saj zdravila Apoquel v teh primerih niso preučevali.
How does Apoquel work?
Kako zdravilo Apoquel deluje?
What is Apoquel?
Kaj je zdravilo Apoquel?
For atopic dermatitis the treatment success rate for Apoquel-treated dogs in the first study was 66% compared with 4% in placebo-treated dogs using pruritus assessment; the results for CADESI scores were 49% and 4% respectively.
Pri preučevanju atopičnega dermatitisa je bila v prvi študiji na podlagi ocenjevanja pruritusa stopnja uspešnosti zdravljenja pri psih, ki so prejemali zdravilo Apoquel, 66 %, pri psih, ki so prejemali placebo, pa 4 %.
• if you are pregnant
če ste noseči
Not known: frequency cannot be estimated from the available data.
Neznana: pogostnosti ni mogoče oceniti iz razpoložljivih podatkov.
I) is excreted in human milk.
I) izloča v človeško mleko.
They should tell you anything you need to do for the safe use of this medicine.
Povedali vam bodo vse, kar morate vedeti za varno uporabo tega zdravila.
Some medicines may reduce the quality of the picture obtained.
Nekatera zdravila lahko zmanjšajo kakovost pridobljene slike.
The following information is intended for the specialist only:
Naslednje informacije so namenjene samo specialistu:
Iodine-123 has a physical half-life of 13.2 hours.
Jod-123 ima fizični razpolovni čas 13,2 ure.
Prior to administration appropriate resuscitation equipment should be available.
Pred dajanjem je treba zagotoviti ustrezno opremo za oživljanje.
It collects in a small area of your brain.
Nabira se v majhnem delu možganov.
Bq/mmol) at reference time.
Bq/mmol) v referenčnem času.
Each dose contains up to 197 mg alcohol.
Vsak odmerek vsebuje do 197 mg alkohola.
It will be passed out of the body in a few days without need for you to take special precautions.
V nekaj dneh se bo izločila iz telesa brez potrebe po dodatnih previdnostnih ukrepih.
I) which is used to help identify (diagnose) conditions in the brain.
I), ki se uporablja za odkrivanje (diagnosticiranje) stanj v možganih.
You will need to be careful with the water (urine) that you pass - your doctor will tell you what to do.
Previdni boste morali biti pri izločanju vode (urina)zdravnik vam bo povedal, kaj morate storiti.
I) are listed in the Table below.
I) so navedeni v spodnji preglednici.
This exposure is less than in some types of X-ray investigation.
Ta izpostavljenost je manjša kot pri nekaterih vrstah rentgenskih pregledov.
Do not exceed 185 MBq and do not use when the activity is below 110 MBq.
Ne presezite 185 MBq in ga ne uporabljajte pri aktivnosti, manjši od 110 MBq.
This can give the doctor valuable information about how that organ is working.
To lahko zdravniku da pomembne podatke o delovanju tega organa.
A scan will give your doctor information about any changes in this area of your brain.
Slika bo vašemu zdravniku dala podatek o kakršnihkoli spremembah v tem delu možganov.
A single injection is enough.
Enkratni odmerek zadostuje.
See also section 6.6.
Glejte tudi poglavje 6.6.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Zahteve gled predložitve rednega posodobljenega poročila o varnosti zdravila za to zdravilo so določene v seznamu referenčnih datumov EU (seznamu EURD), opredeljenem v členu 107c(7) Direktive 2001/83/ES, in vseh kasnejših posodobitvah, objavljenih na evropskem spletnem portalu o zdravilih.
Date of first authorisation: 27 July 2000 Date of latest renewal: 28 July 2010
Datum zadnjega podaljšanja: 28. Julij 2010
Studies on reproductive toxicity and to assess the carcinogenic potential of ioflupane have not been performed.
Študije o toksičnosti za razmnoževanje in za ocenitev karcinogenega potenciala ioflupana niso bile izvedene.
Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥ 1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
Pogostnost neželenih učinkov je opredeljena kot sledi: zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000), zelo redki (<1/10.000) in neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
This is because the child may receive some of the radioactivity.
Razlog za to je, da bi lahko vaš otrok utegnil prejeti nekaj radioaktivnosti.
You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
O neželenih učinkih lahko poročate tudi neposredno na nacionalni center za poročanje , ki je naveden v Prilogi V. S tem, ko poročate o neželenih učinkih, lahko prispevate k zagotovitvi več informacij o varnosti tega zdravila.
This is about the same as 5 ml beer, or 2 ml wine.
To je približno enakovredno 5 ml piva ali 2 ml vina.
Its receipt, storage, use, transfer and disposal are subject to the regulations and the appropriate licences of the local competent official organisations.
Prevzem, shranjevanje, uporabo, prenos in odlaganje uravnavajo predpisi in zahtevajo ustrezna dovoljenja lokalnih pristojnih uradnih organizacij.
It will only be handled and given to you by people who are trained and qualified to use it safely.
Z njim bodo ravnali in vam ga dajali le strokovnjaki, usposobljeni za njegovo varno uporabo.
DaTSCAN is given to you as an injection, usually into a vein in your arm.
Zdravilo DaTSCAN boste prejeli kot injekcijo, ponavadi v veno na roki.
Tell your nuclear medicine doctor if you are taking or have recently taken any other medicines.
Obvestite zdravnika nuklearne medicine, če jemljete ali ste pred kratkim jemali katera koli druga zdravila.
It is used only to identify illness.
Uporablja se samo za odkrivanje bolezni.
Your nuclear medicine doctor will decide the dose that is best for you.
Vaš zdravnik nuklearne medicine bo določil, kakšen odmerek je za vas najboljši.
No data are available (see section 4.4).
Podatki niso na voljo (glejte poglavje 4.4).
It is important that you take the tablets or liquid as the doctor tells you.
Pomembno je, da vzamete tablete ali tekočino po navodilih svojega zdravnika.
Harmful for those suffering from alcoholism.
Škodljiv je za alkoholike.
Hospital staff will ensure that the product is stored and thrown away correctly and not used after the expiry date stated on the label.
Bolnišnično osebje bo zagotovilo, da bo izdelek ustrezno shranjen in pravilno odstranjen ter da ne bo uporabljen po datumu izteka roka uporabnosti, natisnjenem na nalepki.
The safety and efficacy of DaTSCAN in children aged 0 to 18 years has not been established.
Varnost in učinkovitost zdravila DaTSCAN pri otrocih starih 0 do 18 let nista bili dokazani.
The above data are valid in normal pharmacokinetic behaviour.
Zgoraj navedeni podatki veljajo za normalno farmakokinetično delovanje.
Reporting suspected adverse reactions after authorisation of the medicinal product is important.
Poročanje o domnevnih neželenih učinkih zdravila po izdaji dovoljenja je pomembno.
Tell your nuclear medicine doctor if you think you might be pregnant.
Obvestite svojega zdravnika nuklearne medicine, če menite, da utegnete biti noseči.
Ref.: Publication 128 of the Annals of ICRP (Radiation dose to Patients from Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances, 2015
Vir: Objava 128 letopisov organizacije ICRP (Odmerek sevanja pri bolnikih, ki prejmejo radiofarmacevtike: zbirka trenutnihinformacij o pogosto uporabljanih snoveh, 2015)
Children and adolescents DaTSCAN is not recommended for children aged 0 to 18 years
Otroci in mladostniki Zdravilo DaTSCAN ni priporočljivo za otroke stare 0 do 18 let
The amount of radioactivity in the body from DaTSCAN is very small.
Količina radioaktivnosti v telesu zaradi zdravila DaTSCAN je zelo majhna.
I) can be used as a surrogate marker to examine the integrity of the dopaminergic nigrostriatal neurons.
I) uporabimo kot nadomestni označevalec pri raziskavi celovitosti dopaminergičnih nigrostriatalnih nevronov.
12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS
NAVODILA ZA PRIPRAVO RADIOFARMAKOV
In a pivotal clinical trial including evaluation of 288 subjects with dementia with Lewy bodies (DLB) (144 subjects), Alzheimer's disease (124 subjects), vascular dementia (9 subjects) or other (11 subjects), the results of an independent, blinded visual assessment of the DaTSCAN images were compared to the clinical diagnosis as determined by physicians experienced in the management and diagnosis of dementias.
V osrednji klinični študiji, ki je vključevala oceno 288 bolnikov z demenco z Lewyjevimi telesci (DLB) (144 bolnikov), Alzheimerjevo boleznijo (124 bolnikov), vaskularno demenco (9 bolnikov) ter drugih (11 bolnikov), so bili rezultati slepe neodvisne vizualne ocene zdravila DaTSCAN slik primerjani s kliničnimi diagnozami, kot so jih diagnosticirali zdravniki, z izkušnjami v zdravljenju in diagnostiricanju demenc.
Clinical efficacy Clinical studies in patients with dementia with Lewy bodies
Klinična učinkovitost Klinične študije pri bolnikih z demenco z Lewyjevimi telesci
• In adult patients, to help differentiate probable dementia with Lewy bodies from Alzheimer's disease.
• Pri odraslih bolnikih je v pomoč pri razlikovanju verjetne demence z Lewyjevimi telesci od Alzheimerjeve bolezni.
Your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceutical outweighs the risk of being exposed to these small amounts of radiation.
Vaš osebni zdravnik in zdravnik nuklearne medicine sta pretehtala, da klinične koristi tega postopka z radiofarmakom odtehtajo tveganja zaradi izpostavitve majhnim količinam sevanja.
Ioflupane also binds to the serotonin transporter on 5-HT neurons but with lower (approximately 10-fold) binding affinity.
Ioflupan se veže tudi na serotoninske prenašalce na 5-HT nevronih, vendar z ( približno 10-krat ) manjšo afiniteto.
Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Od zdravstvenih delavcev se zahteva, da poročajo o katerem koli domnevnem neželenem učinku na nacionalni center za poročanje, ki je naveden v prilogi V.
The camera pictures are usually taken 3 to 6 hours after the injection of DaTSCAN.
Slikanje s kamero se ponavadi napravi v 3 do 6 urah po injiciranju zdravila DaTSCAN.
To minimise the potential for pain at the injection site during administration, a slow intravenous injection (not less than 15 to 20 seconds) via an arm vein is recommended.
Da bi zmanjšali morebitno bolečino na mestu injiciranja, priporočamo počasno intravensko injekcijo (ne manj kot 15 do 20 sekund) v veno na roki.
Angular sampling should preferably be not less than 120 views over 360 degrees.
Kotno vzorčenje naj bi bilo opravljeno z vsaj 120 pogledi v 360 stopinjah.
Not known: Feeling hot
Ni znano: občutek vročine
Resuscitative medicinal products and equipment (e.g. endotracheal tube and ventilator) have to be readily available.
Zdravila in oprema za oživljanje (npr. endotrahealna cevka in naprava za predihovanje) morajo biti pri roki.
This medicinal product contains 39.5 g/l (5% volume) ethanol (alcohol), up to 197 mg per dose, equivalent to 5 ml beer or 2 ml wine.
To zdravilo vsebuje 39,5 g/l (5 volumskih odstotkov) etanola (alkohola), do 197 mg po odmerku, kar je enakovredno 5 ml piva ali 2 ml vina.
Absorbed radiation dose Gy/MBq
Absorbiran odmerek sevanja Gy/MBq
Do not use DaTSCAN if you are pregnant or think you may possibly be pregnant.
Ne uporabljajte zdravilo DaTSCAN, če ste noseči ali mislite, da bi lahko bili noseči.
This scan will show exactly where the radioactivity is inside the organ and the body.
Ta slika pokaže, kje je radioaktivnost v organu ali telesu.
DaTSCAN is contraindicated in pregnancy (see section 4.3).
Zdravilo DaTSCAN je kontraindicirano med nosečnostjo (glejte poglavje 4.3).
The doctor may ask you to stop taking them for a short time before you receive DaTSCAN.
Zdravnik vas bo morda prosil, da jih za kratek čas, preden prejmete zdravilo DaTSCAN, nehate jemati.
Abnormal images are either asymmetric or symmetric with unequal intensity and/or loss of crescent.
Nenormalne slike so bodisi nesimetrične bodisi simetrične, vendar z neenako intenzivnostjo in/ali nesrpaste oblike.
Excipient(s) with known effect This medicinal product contains 39.5 g/l ethanol.
Pomožne snovi z znanim učinkom To zdravilo vsebuje 39,5 g/l etanola.
About 30% of the whole brain activity is attributed to striatal uptake.
Približno 30 % celotne aktivnosti v možganih pripisujemo privzemu v striatni korpus.
Pharmacotherapeutic group: Diagnostic radiopharmaceutical central nervous system, ATC code: V09AB03.
Farmakoterapevtska skupina: Radiodiagnostiki za ugotavljanje bolezni osrednjega živčevja, oznaka ATC: V09AB03
- Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
- preobčutljivost na učinkovino ali katerokoli pomožno snov iz poglavja 6.1.
I) is cleared rapidly from the blood after intravenous injection; only 5% of the administered activity remains in whole blood at 5 minutes post-injection.
I) se po intravenskem injiciranju hitro očisti iz krvi; 5 minut po injiciranju ostane v krvnem obtoku le 5 % aktivnosti.
SPECT imaging should take place between three and six hours post-injection.
Slikanje SPECT se mora opraviti med tremi in šestimi urami po injiciranju.
To be taken into account in high-risk groups such as patients with liver disease or epilepsy.
To upoštevajte pri visoko rizičnih skupinah kot so bolniki s poškodbo jeter ali epilepsijo.
At 48 hours post-injection, approximately 60% of the injected radioactivity is excreted in the urine, with faecal excretion calculated at approximately 14%.
V 48 urah po injiciranju se približno 60 % radioaktivnosti izloči z urinom; izračuni kažejo, da se z blatom izloči približno 14 %.
The recommended radioactivity given by injection is between 111 to 185 MBq (megabequerel or MBq is a unit used to measure radioactivity).
Priporočena radioaktivnost, aplicirana z injekcijo, je med 111 do 185 MBq (megabequerel ali MBq je merska enota za radioaktivnost).
Exposure to ionising radiation is linked with cancer induction and a potential for development of hereditary defects.
Izpostavljanje ionizacijskemu sevanju je povezano s pojavom raka in z možnostjo razvoja dednih okvar.
Any woman who has missed a period should be assumed pregnant until proven otherwise.
Pri vsaki ženski, ki ji mesečno perilo zamuja, morate predpostaviti, da je noseča, dokler se ne dokaže nasprotno.
Tell your doctor if any of these apply to you.
Obvestite svojega zdravnika, če karkoli od zgoraj naštetega velja za vas.
There is no experience in types of tremor other than essential tremor.
Ni podatkov o drugih vrstah tremorja, razen esencialnega.
If hypersensitivity reactions occur, the administration of the medicinal product must be discontinued immediately and, if necessary, intravenous treatment initiated.
Če se pojavi preobčutljivostna reakcija, je treba dajanje zdravila takoj prekiniti in po potrebi uvesti intravenske zdravljenje.
After use, all materials associated with the preparation and administration of radiopharmaceuticals, including any unused product and its container, should be decontaminated or treated as radioactive waste and disposed of in accordance with the conditions specified by the local competent authority.
Po uporabi morate ves material, uporabljen pri pripravi in uporabi radiofarmakov, vključno z neuporabljenim izdelkom in njegovo ovojnino, dekontaminirati in z njim ravnati kot z radioaktivnim odpadkom ter ga odstraniti v skladu s pogoji, ki jih določa lokalni pristojni organ.
- Pregnancy (see section 4.6).
- nosečnost (glejte poglavje 4.6)
Non-clinical data for ioflupane reveal no special hazard for humans based on conventional studies of safety pharmacology, single and repeated dose toxicity and genotoxicity.
Neklinični podatki za ioflupan ne kažejo na posebne nevarnosti za ljudi na temelju običajne študije farmakološke varnosti, toksičnosti enojnega ali večkratnih odmerkov ter genotoksičnosti.
Your doctor may feel that the scan would help in finding out more about your condition and deciding on possible treatment.
Zdravnik bo morda menil, da mu bo taka slika dodatno pomagala pri poznavanju vaše bolezni in odločanju o morebitnem zdravljenju.
Vascular disorders Not known: Blood pressure decreased
Žilne bolezni Ni znano: znižan krvni tlak
This has been reported among patients receiving DaTSCAN into a small vein.
O tem so poročali pri bolnikih, ki so zdravilo DaTSCAN prejeli v majhno veno.
This is normal practice with medicines like DaTSCAN.
To je običajen postopek pri uporabi zdravil, kakršno je zdravilo DaTSCAN.
The values are calculated assuming urinary bladder emptying at 4.8-hour intervals and appropriate thyroid blocking (Iodine-123 is a known Auger electron emitter).
Pri izračunu vrednosti sta bila predpostavljena praznjenje mehurja v 4,8-urnih presledkih in ustrezno blokiranje ščitnice (jod-123 je znan Augerjev oddajnik elektronov).
For high resolution collimators the radius of rotation should be consistent and set as small as possible (typically 11-15cm).
Pri kolimatorju visoke ločljivosti mora biti polmer obračanja stalen in nastavljen na najmanjšo možno vrednost (praviloma 11 - 15 cm).
It belongs to a group of medicines called “radiopharmaceuticals”, which contain a small amount of radioactivity.
Sodi v skupino zdravil, ki ji rečemo »radiofarmaki«, in je nizko radioaktiven.
General warning Normal safety precautions for handling radioactive materials should be observed.
Splošno opozorilo Uporabite običajne varnostne ukrepe za ravnanje z radioaktivnimi snovmi.
• In adult patients with clinically uncertain Parkinsonian Syndromes, for example those with early symptoms, in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy.
• Pri odraslih bolnikih, pri katerih obstaja sum parkinsonskih sindromov kot na primer tistih z zgodnjimi simptomi, kar omogoči ločevanje esencialnega tremorja od parkinsonskih sindromov, povezanih z idiopatsko Parkinsonovo boleznijo, multiplo sistemsko atrofijo in progresivno supranuklearno paralizo.
Remaining organs Effective Dose (µSv/MBq)
Učinkovit odmerek (µSv/MBq)
The effective dose (E) resulting from administration of 185 MBq of DaTSCAN injection is 4.63 mSv (per 70 kg individual).
Učinkovit odmerek (E), ki nastane z injiciranjem 185 MBq zdravila DaTSCAN, je 4,63 mSv (pri osebi, ki tehta 70 kg).
DaTSCAN should only be used in adult patients referred by physicians experienced in the management of movement disorders and/or dementia.
Zdravilo DaTSCAN uporabljamo le pri odraslih bolnikih, ki jih na pregled napotijo zdravniki, izkušeni v zdravljenju motenj gibanja in/ali demence.